European Multinational Registry on Prevention of Thromboembolic Events in Atrial Fibrillation

European Multinational Registry on Prevention of Thromboembolic Events in Atrial Fibrillation - Prefer in AF

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00003343

Enrollment

5000

Registered

2011-12-14

Start date

2012-01-06

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

MedDRA - 10003658 Atrial Fibrillation I48.19

Interventions

Group 1: • Description of characteristics of AF patients in terms of key (socio-)demographic data, risk factors, method of diagnosis, treatment modalities / • Retrospective documentation of events rel

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Minimum age 18 years / Written informed consent for participation in the registry / History of Atrial Fibrillation documented by electrical tracing (ECG, Holter, pacemaker, implantable cardioverter defibrillator) within the prior 12 months

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

Measure	Time frame
Collection of data of subjects with atrial fibrillation regarding their medical history, their concomitant diseases and their treatment with a focus on the prevention of thromboembolic events.	—

Countries

Austria, France, Germany, Italy, Spain, Switzerland, United Kingdom

Contacts

Public ContactTessa Schliephacke

Daiichi Sankyo Europe GmbH, Clinical Operations

tessa.schliephacke@daiichi-sankyo.eu+49 (0)89 7808-579

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026